Life Sciences workshops - Valuation from a start-up perspective

Date
07.02.2019 13:00 - 18:40
Location
Switzerland Innovation Park Basel Area AG, Room Vision, Gewerbestrasse 24, 4123 Allschwil

The purpose of this workshop is to decrypt the reasons behind using rNPV or VC methodologies to value a product or a Biotech company. 

The risk-adjusted, net present value (rNPV) method is the standard valuation method used within pharma and biotech companies when valuing assets beyond the discovery stage. Well-calibrated the rNPV method is a powerful tool to build, challenge and evaluate the company’s strategy. It also shows how the value of the company develops along reaching milestones. Is it however enough for investors?
 
From an investor’s perspective, it is crucial to understand how long it takes before an exit and what is the potential for ROI (Return on Investment). They need to figure out the conditions to harvest their investment as well as to anticipate the multiple later-round investors and incentive packages to key employees that may dilute their stake. Learn the how’s and when’s of using the rNPV method versus the venture capital method.

Workshop leader: Marie Petit, Villiger Valuation, Basel

Register/Details:

Show All

Events

20.11.2018; 08:00-17:00

venture pitch Zürich

20.11.2018 17:00 - 20:00

Digital Marketing für Startups ZHAW School of Management and Law, Volkartgebäude, Winterthur

21.11.2018 09:00 - 13:30

E-nnovation Awards 2018 Trafo Baden Hotel & Conference Center, Bruggerstrasse 56, 5400 Baden

Show All

Trainings

07.11.2018 13:30 - 28.11.2018 17:30

Fast Track - Sales Academy Lausanne - EPFL Innovation Park

08.11.2018 14:00 - 29.11.2018 18:00

Fast Track - Corporates & Startups: How to develop impactful partnerships EPFL Innovation Park, Lausanne

Principal

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS